Molina Healthcare, Inc (NYSE:MOH) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Molina Healthcare, Inc. (NYSE:MOH) has received an average analyst rating of "Hold" from thirteen research firms, with ten analysts recommending hold and three suggesting buy.
• The company's stock price target has been significantly revised, with Cantor Fitzgerald reducing it from $312.00 to $210.00, while Wells Fargo cut their target from $372.00 to $216.00.
• Molina Healthcare reported $5.48 earnings per share for the last quarter, missing estimates by ($0.02), but achieved a 15.7% increase in revenue year-over-year.

Shares of Molina Healthcare, Inc (NYSE:MOH - Get Free Report) have been given an average recommendation of "Hold" by the thirteen research firms that are presently covering the firm, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $244.5455.

A number of research analysts have recently commented on MOH shares. Cantor Fitzgerald reiterated a "neutral" rating and set a $210.00 target price (down from $312.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Truist Financial restated a "hold" rating and set a $180.00 price target (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Finally, UBS Group decreased their price target on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th.

Molina Healthcare Stock Performance

Shares of NYSE MOH traded down $1.02 during midday trading on Friday, hitting $155.88. 121,853 shares of the company's stock traded hands, compared to its average volume of 955,983. Molina Healthcare has a 1 year low of $151.95 and a 1 year high of $365.23. The stock has a market capitalization of $8.45 billion, a price-to-earnings ratio of 7.75 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a fifty day moving average of $236.76 and a 200 day moving average of $286.75.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The company had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company's revenue was up 15.7% compared to the same quarter last year. During the same quarter last year, the firm posted $5.86 earnings per share. On average, analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other news, COO James Woys acquired 10,000 shares of the company's stock in a transaction dated Monday, August 4th. The shares were acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Amalgamated Bank raised its holdings in Molina Healthcare by 0.3% in the 1st quarter. Amalgamated Bank now owns 11,580 shares of the company's stock valued at $3,814,000 after buying an additional 33 shares during the period. Deseret Mutual Benefit Administrators grew its position in shares of Molina Healthcare by 60.7% during the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after buying an additional 34 shares in the last quarter. JLB & Associates Inc. grew its position in shares of Molina Healthcare by 0.3% during the first quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock worth $3,500,000 after buying an additional 36 shares in the last quarter. PenderFund Capital Management Ltd. lifted its stake in Molina Healthcare by 0.4% during the first quarter. PenderFund Capital Management Ltd. now owns 10,071 shares of the company's stock worth $3,317,000 after purchasing an additional 40 shares during the last quarter. Finally, Coldstream Capital Management Inc. lifted its stake in Molina Healthcare by 2.1% during the fourth quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after purchasing an additional 48 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.